Eric D. Hargan is the Founder and CEO of The Hargan Group, a healthcare consulting firm. Eric previously served as the Deputy Secretary of the Department of Health and Human Services (HHS) from 2017 to 2021; he also served as Acting Secretary for several months in 2017-2018. HHS is the largest department in the federal government and has an annual budget more than $1.3 trillion and over 80,000 employees across 26 divisions. As Deputy Secretary, he oversaw the development and approval of all HHS, CMS, and FDA regulations and significant guidances; as well as the day-to-day operations and management of the department and led policy and strategy development. From 2003 to 2007, Mr. Hargan also served at HHS in a variety of capacities, including holding the position of Acting Deputy Secretary.
As new medical treatments emerge that have the potential to slow aging and extend the human lifespan, a key question is how these longevity therapies will be reimbursed. In this talk, Eric Hargan will discuss the challenges and opportunities for gaining reimbursement and insurance coverage for longevity treatments. He will review the current healthcare reimbursement landscape in the U.S. and how new medical technologies and treatments are evaluated for coverage and payment. He will then explore various strategies for demonstrating the value of longevity therapies to payers and helping these innovative treatments gain coverage and reimbursement.